ROIVANT SCIENCES LTD. (ROIV)

SEC filing

ROIVANT SCIENCES LTD.

ROIV · CIK 1635088

4 · Oct 2, 2026 · President & Immunovant CEO Venker Eric sold 200K Common Shares at $36.62/unit ($7.3M); exercised options for 400K shares

President & Immunovant CEO Venker Eric sold 200K Common Shares at $36.62/unit ($7.3M); exercised options for 400K shares

FORM 4

xslF345X06/wk-form4_1790977058.xmlSEC.gov

Graphics and non-inline formats (not embedded below).